SPDR Gold Trust vs GeneDx Holdings Corp — how do they compare? SPDR Gold Trust trades at $405, while GeneDx Holdings Corp trades at $82.14 (market cap $2.44B). The key difference: SPDR Gold Trust is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| GLD | WGS | |
|---|---|---|
52-Week High | $495.90 | $167.51 |
52-Week Low | $305.27 | $34.51 |
Market Cap | — | $2.44B |
Sector | — | Technology |
Enterprise Value | — | $2.48B |
Signals from Pluang's Aura AI — not financial advice
GLD trades at $403.80, up 0.29% with bullish technical signals from moving averages and strong momentum indicators. The ETF benefits from recent inflation data showing cooling CPI pressures and heightened geopolitical tensions driving safe-haven demand. Recent news highlights gold's resilience amid Federal Reserve policy uncertainty and strong central bank buying activity.
Outlook remains positive with technical resistance at $405-$407 and support at $399-$401. Key risks include potential Fed policy shifts and dollar strength, while catalysts include sustained inflation concerns and geopolitical instability. The ETF's momentum suggests potential for further gains toward resistance levels.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Trailing returns across standard periods
Latest headlines on both assets
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →